ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Coagulation Factor IX Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27I2871
Home | Market Reports | Health| Pharmacy
Global Human Coagulation Factor IX Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Coagulation Factor IX Market Research Report 2025

Code: QYRE-Auto-27I2871
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
Biogen
Octapharma AG
Baxter
Bayer
CSL Limited
Novo Nordisk
Greencross
Kedrion S p A
BPL
Hualan Bio
RAAS
Pfizer Inc

Human Coagulation Factor IX Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Human Coagulation Factor IX Market

Human Coagulation Factor IX Market

The global market for Human Coagulation Factor IX was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor IX, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor IX.
The Human Coagulation Factor IX market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor IX market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor IX manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Coagulation Factor IX Market Report

Report Metric Details
Report Name Human Coagulation Factor IX Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • AHGB
  • AHFB
  • Others
Segment by Application
  • Hospital
  • Personal Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Grifols, Biogen, Octapharma, Baxter, Bayer, CSL, Novo Nordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Coagulation Factor IX in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Human Coagulation Factor IX Market report?

Ans: The main players in the Human Coagulation Factor IX Market are Grifols, Biogen, Octapharma, Baxter, Bayer, CSL, Novo Nordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS, Pfizer

What are the Application segmentation covered in the Human Coagulation Factor IX Market report?

Ans: The Applications covered in the Human Coagulation Factor IX Market report are Hospital, Personal Clinic, Others

What are the Type segmentation covered in the Human Coagulation Factor IX Market report?

Ans: The Types covered in the Human Coagulation Factor IX Market report are AHGB, AHFB, Others

Recommended Reports

Coagulation Devices

Hemostasis Materials

Clotting Factors

1 Human Coagulation Factor IX Market Overview
1.1 Product Definition
1.2 Human Coagulation Factor IX by Type
1.2.1 Global Human Coagulation Factor IX Market Value Comparison by Type (2024 VS 2031)
1.2.2 AHGB
1.2.3 AHFB
1.2.4 Others
1.3 Human Coagulation Factor IX by Application
1.3.1 Global Human Coagulation Factor IX Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Personal Clinic
1.3.4 Others
1.4 Global Human Coagulation Factor IX Market Size Estimates and Forecasts
1.4.1 Global Human Coagulation Factor IX Revenue 2020-2031
1.4.2 Global Human Coagulation Factor IX Sales 2020-2031
1.4.3 Global Human Coagulation Factor IX Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Coagulation Factor IX Market Competition by Manufacturers
2.1 Global Human Coagulation Factor IX Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Coagulation Factor IX Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Coagulation Factor IX Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Coagulation Factor IX, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Coagulation Factor IX, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Coagulation Factor IX, Product Type & Application
2.7 Global Key Manufacturers of Human Coagulation Factor IX, Date of Enter into This Industry
2.8 Global Human Coagulation Factor IX Market Competitive Situation and Trends
2.8.1 Global Human Coagulation Factor IX Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Coagulation Factor IX Players Market Share by Revenue
2.8.3 Global Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Coagulation Factor IX Market Scenario by Region
3.1 Global Human Coagulation Factor IX Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Coagulation Factor IX Sales by Region: 2020-2031
3.2.1 Global Human Coagulation Factor IX Sales by Region: 2020-2025
3.2.2 Global Human Coagulation Factor IX Sales by Region: 2026-2031
3.3 Global Human Coagulation Factor IX Revenue by Region: 2020-2031
3.3.1 Global Human Coagulation Factor IX Revenue by Region: 2020-2025
3.3.2 Global Human Coagulation Factor IX Revenue by Region: 2026-2031
3.4 North America Human Coagulation Factor IX Market Facts & Figures by Country
3.4.1 North America Human Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Coagulation Factor IX Sales by Country (2020-2031)
3.4.3 North America Human Coagulation Factor IX Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Coagulation Factor IX Market Facts & Figures by Country
3.5.1 Europe Human Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Coagulation Factor IX Sales by Country (2020-2031)
3.5.3 Europe Human Coagulation Factor IX Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Coagulation Factor IX Market Facts & Figures by Region
3.6.1 Asia Pacific Human Coagulation Factor IX Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Coagulation Factor IX Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Coagulation Factor IX Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Coagulation Factor IX Market Facts & Figures by Country
3.7.1 Latin America Human Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Coagulation Factor IX Sales by Country (2020-2031)
3.7.3 Latin America Human Coagulation Factor IX Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Coagulation Factor IX Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Coagulation Factor IX Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Coagulation Factor IX Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Coagulation Factor IX Sales by Type (2020-2031)
4.1.1 Global Human Coagulation Factor IX Sales by Type (2020-2025)
4.1.2 Global Human Coagulation Factor IX Sales by Type (2026-2031)
4.1.3 Global Human Coagulation Factor IX Sales Market Share by Type (2020-2031)
4.2 Global Human Coagulation Factor IX Revenue by Type (2020-2031)
4.2.1 Global Human Coagulation Factor IX Revenue by Type (2020-2025)
4.2.2 Global Human Coagulation Factor IX Revenue by Type (2026-2031)
4.2.3 Global Human Coagulation Factor IX Revenue Market Share by Type (2020-2031)
4.3 Global Human Coagulation Factor IX Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Coagulation Factor IX Sales by Application (2020-2031)
5.1.1 Global Human Coagulation Factor IX Sales by Application (2020-2025)
5.1.2 Global Human Coagulation Factor IX Sales by Application (2026-2031)
5.1.3 Global Human Coagulation Factor IX Sales Market Share by Application (2020-2031)
5.2 Global Human Coagulation Factor IX Revenue by Application (2020-2031)
5.2.1 Global Human Coagulation Factor IX Revenue by Application (2020-2025)
5.2.2 Global Human Coagulation Factor IX Revenue by Application (2026-2031)
5.2.3 Global Human Coagulation Factor IX Revenue Market Share by Application (2020-2031)
5.3 Global Human Coagulation Factor IX Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Grifols
6.1.1 Grifols Company Information
6.1.2 Grifols Description and Business Overview
6.1.3 Grifols Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Grifols Human Coagulation Factor IX Product Portfolio
6.1.5 Grifols Recent Developments/Updates
6.2 Biogen
6.2.1 Biogen Company Information
6.2.2 Biogen Description and Business Overview
6.2.3 Biogen Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Biogen Human Coagulation Factor IX Product Portfolio
6.2.5 Biogen Recent Developments/Updates
6.3 Octapharma
6.3.1 Octapharma Company Information
6.3.2 Octapharma Description and Business Overview
6.3.3 Octapharma Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Octapharma Human Coagulation Factor IX Product Portfolio
6.3.5 Octapharma Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Company Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Human Coagulation Factor IX Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Human Coagulation Factor IX Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 CSL
6.6.1 CSL Company Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSL Human Coagulation Factor IX Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Information
6.7.2 Novo Nordisk Description and Business Overview
6.7.3 Novo Nordisk Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novo Nordisk Human Coagulation Factor IX Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Greencross
6.8.1 Greencross Company Information
6.8.2 Greencross Description and Business Overview
6.8.3 Greencross Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Greencross Human Coagulation Factor IX Product Portfolio
6.8.5 Greencross Recent Developments/Updates
6.9 Kedrion
6.9.1 Kedrion Company Information
6.9.2 Kedrion Description and Business Overview
6.9.3 Kedrion Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Kedrion Human Coagulation Factor IX Product Portfolio
6.9.5 Kedrion Recent Developments/Updates
6.10 BPL
6.10.1 BPL Company Information
6.10.2 BPL Description and Business Overview
6.10.3 BPL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.10.4 BPL Human Coagulation Factor IX Product Portfolio
6.10.5 BPL Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Company Information
6.11.2 Hualan Bio Description and Business Overview
6.11.3 Hualan Bio Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hualan Bio Human Coagulation Factor IX Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 RAAS
6.12.1 RAAS Company Information
6.12.2 RAAS Description and Business Overview
6.12.3 RAAS Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.12.4 RAAS Human Coagulation Factor IX Product Portfolio
6.12.5 RAAS Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Company Information
6.13.2 Pfizer Description and Business Overview
6.13.3 Pfizer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pfizer Human Coagulation Factor IX Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Coagulation Factor IX Industry Chain Analysis
7.2 Human Coagulation Factor IX Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Coagulation Factor IX Production Mode & Process Analysis
7.4 Human Coagulation Factor IX Sales and Marketing
7.4.1 Human Coagulation Factor IX Sales Channels
7.4.2 Human Coagulation Factor IX Distributors
7.5 Human Coagulation Factor IX Customer Analysis
8 Human Coagulation Factor IX Market Dynamics
8.1 Human Coagulation Factor IX Industry Trends
8.2 Human Coagulation Factor IX Market Drivers
8.3 Human Coagulation Factor IX Market Challenges
8.4 Human Coagulation Factor IX Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Grifols S A
Biogen
Octapharma AG
Baxter
Bayer
CSL Limited
Novo Nordisk
Greencross
Kedrion S p A
BPL
Hualan Bio
RAAS
Pfizer Inc
List of Tables
 Table 1. Global Human Coagulation Factor IX Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Coagulation Factor IX Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Coagulation Factor IX Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Coagulation Factor IX Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Human Coagulation Factor IX Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Coagulation Factor IX Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Coagulation Factor IX Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Coagulation Factor IX Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Coagulation Factor IX, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Coagulation Factor IX, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Coagulation Factor IX, Product Type & Application
 Table 12. Global Key Manufacturers of Human Coagulation Factor IX, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Coagulation Factor IX by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor IX as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Coagulation Factor IX Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Coagulation Factor IX Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Human Coagulation Factor IX Sales Market Share by Region (2020-2025)
 Table 19. Global Human Coagulation Factor IX Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Human Coagulation Factor IX Sales Market Share by Region (2026-2031)
 Table 21. Global Human Coagulation Factor IX Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Coagulation Factor IX Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Coagulation Factor IX Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Coagulation Factor IX Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Coagulation Factor IX Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Human Coagulation Factor IX Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Human Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Coagulation Factor IX Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Human Coagulation Factor IX Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Human Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Coagulation Factor IX Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Coagulation Factor IX Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Human Coagulation Factor IX Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Human Coagulation Factor IX Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Coagulation Factor IX Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Coagulation Factor IX Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Human Coagulation Factor IX Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Human Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Coagulation Factor IX Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Human Coagulation Factor IX Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Human Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Coagulation Factor IX Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Human Coagulation Factor IX Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Human Coagulation Factor IX Sales Market Share by Type (2020-2025)
 Table 53. Global Human Coagulation Factor IX Sales Market Share by Type (2026-2031)
 Table 54. Global Human Coagulation Factor IX Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Coagulation Factor IX Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Coagulation Factor IX Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Coagulation Factor IX Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Coagulation Factor IX Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Human Coagulation Factor IX Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Human Coagulation Factor IX Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Human Coagulation Factor IX Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Human Coagulation Factor IX Sales Market Share by Application (2020-2025)
 Table 63. Global Human Coagulation Factor IX Sales Market Share by Application (2026-2031)
 Table 64. Global Human Coagulation Factor IX Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Coagulation Factor IX Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Coagulation Factor IX Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Coagulation Factor IX Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Coagulation Factor IX Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Human Coagulation Factor IX Price (USD/Pcs) by Application (2026-2031)
 Table 70. Grifols Company Information
 Table 71. Grifols Description and Business Overview
 Table 72. Grifols Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Grifols Human Coagulation Factor IX Product
 Table 74. Grifols Recent Developments/Updates
 Table 75. Biogen Company Information
 Table 76. Biogen Description and Business Overview
 Table 77. Biogen Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Biogen Human Coagulation Factor IX Product
 Table 79. Biogen Recent Developments/Updates
 Table 80. Octapharma Company Information
 Table 81. Octapharma Description and Business Overview
 Table 82. Octapharma Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Octapharma Human Coagulation Factor IX Product
 Table 84. Octapharma Recent Developments/Updates
 Table 85. Baxter Company Information
 Table 86. Baxter Description and Business Overview
 Table 87. Baxter Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Baxter Human Coagulation Factor IX Product
 Table 89. Baxter Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Bayer Human Coagulation Factor IX Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. CSL Company Information
 Table 96. CSL Description and Business Overview
 Table 97. CSL Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. CSL Human Coagulation Factor IX Product
 Table 99. CSL Recent Developments/Updates
 Table 100. Novo Nordisk Company Information
 Table 101. Novo Nordisk Description and Business Overview
 Table 102. Novo Nordisk Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Novo Nordisk Human Coagulation Factor IX Product
 Table 104. Novo Nordisk Recent Developments/Updates
 Table 105. Greencross Company Information
 Table 106. Greencross Description and Business Overview
 Table 107. Greencross Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Greencross Human Coagulation Factor IX Product
 Table 109. Greencross Recent Developments/Updates
 Table 110. Kedrion Company Information
 Table 111. Kedrion Description and Business Overview
 Table 112. Kedrion Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Kedrion Human Coagulation Factor IX Product
 Table 114. Kedrion Recent Developments/Updates
 Table 115. BPL Company Information
 Table 116. BPL Description and Business Overview
 Table 117. BPL Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. BPL Human Coagulation Factor IX Product
 Table 119. BPL Recent Developments/Updates
 Table 120. Hualan Bio Company Information
 Table 121. Hualan Bio Description and Business Overview
 Table 122. Hualan Bio Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Hualan Bio Human Coagulation Factor IX Product
 Table 124. Hualan Bio Recent Developments/Updates
 Table 125. RAAS Company Information
 Table 126. RAAS Description and Business Overview
 Table 127. RAAS Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. RAAS Human Coagulation Factor IX Product
 Table 129. RAAS Recent Developments/Updates
 Table 130. Pfizer Company Information
 Table 131. Pfizer Description and Business Overview
 Table 132. Pfizer Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Pfizer Human Coagulation Factor IX Product
 Table 134. Pfizer Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Human Coagulation Factor IX Distributors List
 Table 138. Human Coagulation Factor IX Customers List
 Table 139. Human Coagulation Factor IX Market Trends
 Table 140. Human Coagulation Factor IX Market Drivers
 Table 141. Human Coagulation Factor IX Market Challenges
 Table 142. Human Coagulation Factor IX Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Coagulation Factor IX
 Figure 2. Global Human Coagulation Factor IX Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Coagulation Factor IX Market Share by Type: 2024 & 2031
 Figure 4. AHGB Product Picture
 Figure 5. AHFB Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Human Coagulation Factor IX Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Human Coagulation Factor IX Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Personal Clinic
 Figure 11. Others
 Figure 12. Global Human Coagulation Factor IX Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Human Coagulation Factor IX Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Human Coagulation Factor IX Sales (2020-2031) & (K Pcs)
 Figure 15. Global Human Coagulation Factor IX Average Price (USD/Pcs) & (2020-2031)
 Figure 16. Human Coagulation Factor IX Report Years Considered
 Figure 17. Human Coagulation Factor IX Sales Share by Manufacturers in 2024
 Figure 18. Global Human Coagulation Factor IX Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Human Coagulation Factor IX Players: Market Share by Revenue in Human Coagulation Factor IX in 2024
 Figure 20. Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Human Coagulation Factor IX Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Human Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 23. North America Human Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Human Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 27. Europe Human Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Human Coagulation Factor IX Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Human Coagulation Factor IX Revenue Market Share by Region (2020-2031)
 Figure 35. China Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Human Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Human Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Human Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Human Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Human Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Human Coagulation Factor IX by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Human Coagulation Factor IX by Type (2020-2031)
 Figure 57. Global Human Coagulation Factor IX Price (USD/Pcs) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Human Coagulation Factor IX by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Human Coagulation Factor IX by Application (2020-2031)
 Figure 60. Global Human Coagulation Factor IX Price (USD/Pcs) by Application (2020-2031)
 Figure 61. Human Coagulation Factor IX Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Human Coagulation Factor IV Market Research Report 2024
Human Coagulation Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor IX Market Research Report 2025
Global Coagulase Plasma Market Research Report 2025
Global Human Antithrombin III Market Research Report 2024
Global Haemostat Market Research Report 2025
Global Blood Coagulation Monitor Market Research Report 2025
Global Point Of Care Coagulation Testing Devices Market Research Report 2025
Global Coagulation Hemostasis Analyzer Market Research Report 2025
Coagulation Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coagulation Filter Market Research Report 2024
Global Thrombin Human Market Research Report 2025
Global Hemostat Market Research Report 2024
Automated Coagulation Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Coagulation Analyzer Market Research Report 2025
Global Blood Coagulation Analyzers Market Research Report 2025
Automated Coagulation Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
4 Channel Coagulometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mechanical Hemostasis and Coagulation Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Jet Lag Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0R20253
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions